You just read:

Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

News provided by

Jazz Pharmaceuticals

Mar 20, 2019, 18:53 ET